RxDoctor Payments Data

Daniel Galat, MD

Adult Reconstructive Orthopaedic Surgery · Scottsdale, AZNPI 1104803949

Payments from drug & device makers

What this record shows

Stryker accounts for 85.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $4,611 and has fallen 82.3% since, to $817 in 2025.

$11,736in general payments, 2019–2025

Across 119 payments — averaging $98.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$10K
  • Johnson & Johnson$762
  • Zimmer Biomet$444
  • Smith+Nephew$331
  • Nalu Medical, Inc.$121
  • Davol Inc.$23
  • plus $76 from 5 others

What the payments were for

  • Travel & lodging$5,43246%
  • Food & beverage$6,30554%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,736 in reported general payments places this provider in the 60th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$269,834
Medicare patients
333
Services billed
2,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron120$959
Meloxicam303$654
CefuroximeCefuroxime Axetil133$577
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$200

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →